Overview
Efficacy Study of a Low Volume of Water Intake and Mosapride for Endoscopy in Patients With Subtotal Gastrectomy
Status:
Completed
Completed
Trial end date:
2011-09-01
2011-09-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
A low volume of water intake and mosapride will effectively reduce food residue in remnant stomach for patients who had undergone subtotal gastrectomy due to gastric cancer.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Inje UniversityTreatments:
Mosapride
Criteria
Inclusion Criteria:- Outpatients who had subtotal gastrectomy for gastric cancer
Exclusion Criteria:
- Pregnancy
- Lactation
- History of anastomotic stricture
- Recurrent advanced gastric cancer
- Poor general condition( > 2 ECOG)
- Other disseminated malignancy
- Significant renal failure or congestive heart failure (CHF)
- Liver failure